We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
+27.04%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+505.55%
AUM
$329B
AUM Growth
+$45.5B
Cap. Flow
-$19.5B
Cap. Flow %
-5.91%
Top 10 Hldgs %
19.09%
Holding
5,697
New
507
Increased
1,879
Reduced
2,401
Closed
535

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.38B
2
AGN
Allergan plc
AGN
+$1.33B
3
MSFT icon
Microsoft
MSFT
+$961M
4
QQQ icon
Invesco QQQ Trust
QQQ
+$803M
5
AMZN icon
Amazon
AMZN
+$740M

Sector Composition

Rank Sector Weight
1 Technology 14.8%
2 Healthcare 9.1%
3 Financials 9.05%
4 Consumer Discretionary 8.76%
5 Communication Services 6.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HTB
4001
HomeTrust Bancshares
HTB
$863M
$847K ﹤0.01%
52,940
+18,730
+55% +$282K
FMCIW
4002
DELISTED
Forum Merger II Corporation Warrant
FMCIW
$846K ﹤0.01%
180,000
OVID icon
4003
Ovid Therapeutics
OVID
$495M
$845K ﹤0.01%
114,674
-21,577
-16% -$101K
DECK icon
4004
PUT
Deckers Outdoor
DECK
$13.3B
$844K ﹤0.01%
25,800
ASIX icon
4005
AdvanSix
ASIX
$543M
$841K ﹤0.01%
71,629
-147,387
-67% -$1.72M
ONEO icon
4006
State Street SPDR Russell 1000 Momentum Focus ETF
ONEO
$29.6M
$841K ﹤0.01%
12,268
ARVN icon
4007
CALL
Arvinas
ARVN
$560M
$838K ﹤0.01%
+25,000
New +$1.06M
DHS icon
4008
WisdomTree US High Dividend Fund
DHS
$1.57B
$837K ﹤0.01%
13,440
+2,585
+24% +$159K
XSLV icon
4009
Invesco S&P SmallCap Low Volatility ETF
XSLV
$247M
$837K ﹤0.01%
+24,721
New +$821K
LH icon
4010
CALL
Labcorp
LH
$25.6B
$831K ﹤0.01%
5,820
-32,592
-85% -$4.51M
GPOR
4011
DELISTED
Gulfport Energy Corp.
GPOR
$830K ﹤0.01%
762,260
-819,061
-52% -$1.22M
ADRE
4012
DELISTED
Invesco BLDRS Emerging Markets 50 ADR Index Fund
ADRE
$828K ﹤0.01%
20,940
ALLY icon
4013
CALL
Ally Financial
ALLY
$13.4B
$827K ﹤0.01%
+41,700
New +$709K
MGC icon
4014
Vanguard Morningstar Mega Cap ETF
MGC
$10.3B
$827K ﹤0.01%
7,557
SRRK icon
4015
Scholar Rock
SRRK
$6.31B
$827K ﹤0.01%
45,415
+21,432
+89% +$365K
HCAT icon
4016
Health Catalyst
HCAT
$171M
$825K ﹤0.01%
28,282
+696
+3% +$19.2K
TKC icon
4017
Turkcell
TKC
$4.76B
$823K ﹤0.01%
142,819
+84,599
+145% +$432K
CALA
4018
DELISTED
Calithera Biosciences, Inc
CALA
$823K ﹤0.01%
7,789
+1,971
+34% +$234K
TTCF
4019
DELISTED
Tattooed Chef, Inc Class A Common Stock
TTCF
$822K ﹤0.01%
50,000
-100,000
-67% -$1.23M
IMMU
4020
CALL
DELISTED
Immunomedics Inc
IMMU
$822K ﹤0.01%
+23,200
New +$678K
IHE icon
4021
iShares US Pharmaceuticals ETF
IHE
$1.64B
$821K ﹤0.01%
16,014
+9,000
+128% +$452K
LBRT icon
4022
Liberty Energy
LBRT
$3.27B
$821K ﹤0.01%
149,848
+31,604
+27% +$148K
UGP icon
4023
Ultrapar
UGP
$6.81B
$819K ﹤0.01%
241,751
-96,083
-28% -$283K
BRMK
4024
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
$818K ﹤0.01%
86,399
-539,644
-86% -$4.56M
KNOP icon
4025
KNOT Offshore Partners
KNOP
$368M
$816K ﹤0.01%
59,298
-3,236
-5% -$44.3K

Similar funds

Goldman Sachs's Q2 2020 Portfolio in Review

As of Q2 2020, Goldman Sachs held 5,697 positions worth $329B, up 16% from $284B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Goldman Sachs withdrew a net $19.5B in Q2 2020, closing 535 positions and reducing 2,401 holdings. Its most notable exit was Allergan plc, an estimated $1.33B position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Goldman Sachs opened a new position in Goldman Sachs MarketBeta US Equity ETF worth $209M.

  • Goldman Sachs's largest Q2 2020 buy was Goldman Sachs MarketBeta US Equity ETF: 4,910,076 shares worth $209M.
  • Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $2.58B increase.
  • Goldman Sachs's biggest Q2 2020 reduction was Apple, cutting an estimated $1.38B.
  • Goldman Sachs fully exited Allergan plc in Q2 2020, selling an estimated $1.33B.
  • Goldman Sachs's ten largest holdings make up 19% of its $329B portfolio in Q2 2020.
  • Goldman Sachs opened 507 new positions and closed 535 in Q2 2020.
  • Goldman Sachs's portfolio value rose 16% quarter-over-quarter to $329B.

Based on Goldman Sachs's 13F filing for Q2 2020, filed 12 Aug 2020.